Zobrazeno 1 - 10
of 93
pro vyhledávání: '"G Wiederrecht"'
Autor:
Abul K. Abbas, G. Wiederrecht, Bo Zhang, Dan Ladd, Jianzhu Chen, E Li, Christine E. Seidman, G J Zimmer, E A O'Neill, Frederick W. Alt, J Cryan, Jonathan G. Seidman
Publikováno v:
The Journal of Experimental Medicine
We have created embryonic stem (ES) cells and mice lacking the predominant isoform (alpha) of the calcineurin A subunit (CNA alpha) to study the role of this serine/threonine phosphatase in the immune system. T and B cell maturation appeared to be no
Publikováno v:
Journal of Biological Chemistry. 268:22992-22999
The ryanodine receptor/calcium release channel (CRC) of rabbit skeletal muscle terminal cisternae (TC) of sarcoplasmic reticulum (SR) has been found to be tightly associated with FK-506 binding protein (FKBP-12), the cytosolic receptor (immunophilin)
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
G, Wiederrecht, J J, Siekierka
Publikováno v:
Methods in enzymology. 290
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
F J, Dumont, H, Ok, S, Lin, C A, Kastner, J, Cryan, M M, Martin, G, Wiederrecht, M J, Staruch
Publikováno v:
The Journal of pharmacology and experimental therapeutics. 276(3)
FK-506 blocks T cell activation by preventing lymphokine gene transcription through formation of a complex with FKBP12 that inhibits calcineurin phosphatase activity. Immunosuppressive FK-506 analogs (agonists) have been generated whose potency corre
Publikováno v:
The Journal of biological chemistry. 270(6)
FKBP-12 (FKBP), the soluble receptor for the immunosuppresant drug FK-506, is tightly bound to the calcium release channel (CRC)/ryanodine receptor (RyR) of skeletal muscle terminal cisternae (TC) of sarcoplasmic reticulum with a stoichiometry of 4 m
Publikováno v:
The Journal of biological chemistry. 268(30)
The immunosuppressant rapamycin (RAP) is a potent inhibitor of the entry of interleukin (IL)-2-stimulated T cells into S-phase. Earlier results indicated that RAP treatment arrested the growth of the murine IL-2-dependent T cell line CTLL-2 in late G
Autor:
J W, Becker, J, Rotonda, B M, McKeever, H K, Chan, A I, Marcy, G, Wiederrecht, J D, Hermes, J P, Springer
Publikováno v:
The Journal of biological chemistry. 268(15)
L-685,818 differs only slightly in structure from the immunosuppressive drug FK-506, and both compounds bind with comparable affinity to the 12-kDa FK-506-binding protein (FKBP12), the major intracellular receptor for the drug. Despite these similari
Publikováno v:
The Journal of biological chemistry. 268(5)
The macrolide rapamycin (RAP) is a potent inhibitor of interleukin-2 (IL-2)-induced T-cell proliferation. Current models suggest that RAP, when complexed to its intracellular receptor, FK506-binding protein, interferes with an IL-2 receptor-coupled s